/
/
/

Genomic Valley Biotech Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)0.00
Volume (₹)0.00
High (₹)0.00
Upper Circuit31.37
Low (₹)0.00
Lower Circuit28.39
Prev Close29.88
52W High (₹)41.95
Price29.88
52W Low (₹)20.10

Share Market Cap & Key Ratios Overview

M.Cap (₹)9.13 Cr
Div. Yield (%)0.00
PE Ratio434.61
Debt to Equity0.00
Price to Book4.59
Book Value12.76
EPS (TTM)0.07
Face Value10.00
ROE (%)9.57

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
MGEL-TNSE
KOTYARK-TNSE
GVBL-XNSE
LTP
1W Low
1W High
Market cap (₹)
14.11-0.37 (-2.56%)
13.82
14.72
477Cr
33.75-0.35 (-1.03%)
30.46
34.64
364Cr
29.88+1.01 (3.50%)
27.25
30
9Cr

Key Highlights of Genomic Valley Biotech Ltd Balance Sheet

Genomic Valley Biotech Ltd balance sheet discloses shareholders' funds of ₹3.05Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹3.05Cr, and the reserves and surplus of the company is ₹84.37Lakh.

The company has its non-current liabilities with total liabilities of ₹4.36Cr as of 2025-03-31.

The current liabilities are ₹45.79Lakh as of 2025-03-31. At the same time, current assets are ₹2.62Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of 0 and tangible assets of 87004, provided in the Genomic Valley Biotech Ltd financial statements.